# A strategic reserve of essential generic cancer drugs to end recurring shortages

Source: https://onco.cc/ideas/idea-reg-generic-chemo-strategic-reserve/  
OnCo record `idea-reg-generic-chemo-strategic-reserve` (Idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Cancer patients have had treatments delayed because basic chemotherapy drugs ran out. Keeping a national stockpile, like for flu antivirals, would prevent this.

## Summary

Shortages of cisplatin, carboplatin, methotrexate, fluorouracil and other essential generics recur every few years in high-income countries and chronically in LMICs, usually after a single manufacturer's quality failure. Several countries hold strategic reserves of antivirals and antibiotics; none holds oncology essentials. The proposal is a rotating national or regional reserve covering six months of demand for the 20 most shortage-prone oncology generics, with stock rotated through normal supply chains to avoid waste, procurement rules that require dual sourcing, and automatic release triggers.

## Fields

- Kind: Idea
- Last checked: 2026-09-08
- Hypothesis: Reserves eliminate treatment delays and dose modifications attributed to shortages of covered drugs and reduce shortage-related switching to inferior regimens to near zero.
- Rationale: The drugs are cheap and stable, the shortage cost (delayed curative treatment) is very high, and the reserve approach has worked for other essential medicines; the barrier is only that no one has been made responsible.
- Proposed test: Establish a reserve for ten drugs in one country and compare shortage-related treatment delays with the prior three years and with peer countries.
- Maturity: early-clinical
- Actor: policy

## Sources

- Bottleneck evidence (No incentive to repurpose cheap drugs): Pantziarka et al., The Repurposing Drugs in Oncology (ReDO) Project (ecancer 2014): https://doi.org/10.3332/ecancer.2014.442

## Connected records

- technologies: [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Paclitaxel / nab-paclitaxel](https://onco.cc/drugs/paclitaxel/)
- bottlenecks: [Most of the world has almost no cancer care](https://onco.cc/bottlenecks/b-global-access/), [No incentive to repurpose cheap drugs](https://onco.cc/bottlenecks/b-generic-repurposing/)
- key papers: [The Repurposing Drugs in Oncology (ReDO) Project](https://onco.cc/key-papers/paper-pantziarka-ecancermedicalscience/)
- roadmaps: [Chemotherapy roadmap: mustard gas → curative combinations → the warhead inside smarter drugs](https://onco.cc/roadmaps/chemotherapy-roadmap/)

---
JSON: https://onco.cc/api/v1/entities/idea-reg-generic-chemo-strategic-reserve.json